International Biotechnology Trust PLC Aerie Pharmaceuticals Inc Transaction History

International Biotechnology Trust PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$28.97 - $48.21 $4.38 Million - $7.29 Million	-151,117 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$36.32 - $49.25 $4.94 Million - $6.7 Million	136,117 Added 907.45%	151,117 $7.18 Million
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $3.64 Million - $6.62 Million	-110,179 Reduced 88.02%	15,000 $425,000
Q3 2018 Nov 14, 2018	SELL	$56.15 - $73.9 $13.7 Million - $18.1 Million	-244,821 Reduced 66.17%	125,179 $5.91 Million
Q3 2018 Nov 13, 2018	BUY	$56.15 - $73.9 $19.9 Million - $26.3 Million	355,221 Added 2403.55%	370,000 $5.67 Million
Q3 2017 Mar 02, 2018	SELL	$48.6 - $60.1 $3.84 Million - $4.75 Million	-79,043 Reduced 84.25%	14,779 $718,000
Q2 2017 Mar 02, 2018	BUY	N/A	78,822 Added 525.48%	93,822 $4.93 Million
Q1 2017 Mar 02, 2018	SELL	N/A	-123,000 Reduced 89.13%	15,000 $680,000
Q4 2016 Mar 02, 2018	BUY	N/A	138,000	138,000 $5.21 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.